Financial Performance - The company reported a total revenue of RMB 1.2 billion for the year 2022, representing a year-over-year growth of 15%[11]. - The company achieved operating revenue of CNY 551.86 million in 2022, representing a year-on-year increase of 15.98%[23]. - Net profit attributable to shareholders of the listed company was CNY 127.09 million, up 87.56% compared to the previous year[25]. - Basic and diluted earnings per share were both CNY 1.41, reflecting a growth of 41% year-on-year[24]. - The company reported a significant increase in financial management income due to improved management of idle funds[26]. - The company achieved a revenue of 551.86 million yuan in 2022, representing a year-on-year growth of 15.98%[35]. - The net profit attributable to shareholders was 127.09 million yuan, with a significant year-on-year increase of 87.56%[35]. - The company reported a gross margin of 40% for 2022, indicating strong operational efficiency and cost management[22]. - The company reported a revenue of 1.5 billion in 2022, representing a year-over-year growth of 15%[194]. - The company reported a revenue increase of 15% year-over-year, reaching $1.2 billion for the fiscal year 2022[199]. Dividend and Share Capital - The company plans to distribute a cash dividend of 4.27 CNY per 10 shares, totaling approximately 38.41 million CNY, which represents 30.22% of the net profit attributable to shareholders for 2022[4]. - The total share capital of the company as of December 31, 2022, is 89,960,000 shares[4]. - The board of directors has approved the profit distribution plan, pending shareholder approval[4]. Research and Development - The company plans to invest 100 million RMB in R&D for the next fiscal year to accelerate innovation in optical systems[22]. - Research and development expenses accounted for 13.89% of operating revenue, a decrease of 0.36 percentage points from the previous year[24]. - The total R&D investment for the year was approximately ¥76.67 million, an increase of 13.11% compared to the previous year's ¥67.79 million[96]. - The company applied for 82 new patents during the reporting period, with 23 patents granted, bringing the total granted patents to 702[93]. - The company has established a strong R&D pipeline with multiple projects aimed at achieving global advanced technology levels[98]. Market Expansion and Strategy - The company is expanding its market presence in Europe, aiming for a 25% increase in sales in that region[11]. - Market expansion plans include entering the Southeast Asian market, targeting a 10% market share within the next two years[22]. - The company is actively expanding into emerging applications such as intelligent assisted driving and semiconductor integrated circuit manufacturing, where sales currently represent a relatively low proportion of total revenue[116]. - The company is focusing on three strategic application areas: automotive applications, semiconductor processes, and medical health, providing core components and solutions to different customers[120]. - The company is considering strategic acquisitions to bolster its market position, with a budget of $100 million allocated for potential deals[195]. Operational Efficiency and Cost Management - Future outlook includes a focus on sustainable practices, aiming to reduce operational costs by 15% through energy-efficient technologies[12]. - The company aims to reduce operational costs by 5% through efficiency improvements in 2023[194]. - The company has implemented cost-cutting measures expected to save $30 million annually[195]. - The company’s product gross margin remains relatively high, but future declines in the laser industry could lead to significant impacts on performance[114]. Risks and Challenges - The company has detailed various operational risks and corresponding countermeasures in the report[3]. - The company faces risks related to core technology leakage and talent loss, which could adversely affect its competitive edge[108]. - The company is experiencing delays in the mass production of laser radar modules due to disagreements with a key client, potentially affecting future automotive business revenue[111]. - The company’s foreign revenue is significantly impacted by exchange rate fluctuations, primarily in euros and US dollars, posing a risk to pricing and profit margins[114]. Product Development and Innovation - New product development includes the launch of a high-power semiconductor laser, expected to enhance market competitiveness[12]. - The company has launched a new line of UV-L products, which is anticipated to contribute an additional 200 million RMB in revenue in 2023[22]. - The company is developing new technologies in laser welding and 3D sensing, with expected completion by Q3 2023[22]. - The company is focusing on expanding its product lines in the medical aesthetics sector, with applications in laser hair removal and skin rejuvenation[49]. Customer Engagement and Satisfaction - User data indicates an increase in active customers by 20%, reaching a total of 500,000 users by the end of 2022[12]. - Customer satisfaction ratings improved to 90%, reflecting enhanced service and product quality[194]. - The company’s sales team actively participates in industry exhibitions and technical forums to strengthen strategic partnerships with key customers[66]. Corporate Governance - The company has not disclosed any special arrangements for corporate governance[5]. - The company has established an information disclosure management system that complies with the "Confidentiality Law" and has effectively executed it to prevent leakage of confidential information[180]. - The company has maintained a consistent shareholding structure, with no changes in the number of shares held by key personnel during the reporting period[186].

编制单位：西安炬光科技股份有限公司 单位：元 币种：人民币 审计类型：未经审计 2023 年起首次执行新会计准则或准则解释等涉及调整首次执行当年年初的财务报表 □适用 √不适用 (二)财务报表 (一)审计意见类型 □适用 √不适用 公司负责人：刘兴胜 主管会计工作负责人：徐影 会计机构负责人：徐影 合并利润表 2023 年 1—3 月 编制单位：西安炬光科技股份有限公司 编制单位:西安炬光科技股份有限公司 项目 2023 年 3 月 31 日 2022 年 12 月 31 日 | --- | --- | --- | --- | |--------------|--------------------|------------------|----------------| | | | | | | 流动资产： | | | | | 货币资金 | | 1,185,601,614.01 | 969,194,635.04 | | 结算备付金 | | | | | 拆出资金 | | | | | | 交易性金融资产 | 407,068,530.87 | 737,349,255.93 | | 衍生金融资产 | | | | | ...

证券代码：688167 证券简称：炬光科技 公告编号：2023-038 西安炬光科技股份有限公司 关于召开 2022 年度暨 2023 年第一季度 业绩说明会的公告 本公司董事会及全体董事保证公告内容不存在任何虚假记载、误导性陈述或者 重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： 会议召开时间：2023 年 4 月 27 日（星期四）14:30-17:00 会议召开方式：线上视频会议 1、电脑端参会：https://s.comein.cn/ANVgW 2、手机端参会：登陆进门财经 APP/进门财经小程序，搜索"688167"、"炬 光科技"进入"炬光科技（688167）2022 年度暨 2023 年第一季度网上业绩说明 会"，或扫描下方二维码参会： 3、电话端参会： +852-30183474（中国香港） +86-01053827720（全球） 参会密码：345713 会议问题征集：投资者可于 2023 年 4 月 27 日（星期四）14:30 前访问网址 https://s.comein.cn/ANVYz 或扫描下方二维码进行会前问题征集。 西安炬光科技股份有限公司（以下简 ...

证券代码： 688167 证券简称： 炬光科技 西安炬光科技股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------------------|-----------------------------------|--------------------------------------------------| | | | | | 投资者关系活动类别 | 特定对象调研 | 分析师会议 | | | 媒体采访 | 业绩说明会 | | | 新闻发布会 | 路演活动 | | | 现场参观 | 电话会议 | | | 其他 | （请文字说明其他活动内容） | | 参与单位名称及人员姓名 | 见附件 | | | 会议时间 | 2022 年 4 月 28 日 14 | ： 00 | | 会议地点 | | 西安炬光科技股份有限公司（现场或电话） | | 上市公司接待人员姓名 | 董事长 / 总经理：刘兴胜 | | | | 董事 / 副总经理：田野 | | | | 汽车业务运营负责人：朱国巍 | | | | 汽车业务负责人：李勇 | | | | 激光光学业务负责人：田勇 | | ...

证券代码： 688167 证券简称： 炬光科技 西安炬光科技股份有限公司 投资者关系活动记录表 编号：2022-047 至 2022-049 | --- | --- | --- | |-------------------------------------------------|----------------------------|--------------------------------------------------------| | | | | | 投资者关系活动类别 | 特定对象调研 | 分析师会议 | | | 媒体采访 | 业绩说明会 | | | 新闻发布会 | 路演活动 | | | 现场参观 | 电话会议 | | | 其他 | （请文字说明其他活动内容） | | 参与单位名称及人员姓名 | 见附件 | | | 会议时间 2022 | 年 5 月 5 日 -2022 | 年 5 月 27 日 | | 会议地点 西安炬光科技股份有限公司（现场或电话） | | | | 上市公司接待人员姓名 董事长/总经理：刘兴胜 | | | | | 董事/副总经理：田野 | | | | 汽车业务负责人 ...

Financial Performance - The company's operating revenue for Q3 2022 was ¥135,478,476.60, representing an increase of 8.17% compared to the same period last year[6]. - The net profit attributable to shareholders for Q3 2022 was ¥37,872,334.44, showing a significant increase of 60.67% year-over-year[6]. - The net profit attributable to shareholders after deducting non-recurring gains and losses for the year-to-date was ¥68,448,758.16, reflecting a growth of 57.08% compared to the previous year[10]. - Total operating revenue for the first three quarters of 2022 reached CNY 399,127,574, an increase of 16.3% compared to CNY 342,894,449.21 in the same period of 2021[38]. - Net profit for the third quarter of 2022 was CNY 106,273,813.69, compared to CNY 54,393,235.15 in the previous year, marking a significant increase of 95.5%[41]. - The total comprehensive income for the third quarter was CNY 104,581,709.19, compared to CNY 45,487,078.07 in the same period last year, showing an increase of 130%[44]. Research and Development - Research and development expenses for Q3 2022 totaled ¥22,600,089.22, which is an increase of 48.66% compared to the same period last year[10]. - The ratio of R&D expenses to operating revenue for Q3 2022 was 16.68%, an increase of 4.54 percentage points year-over-year[10]. - Research and development expenses for the first three quarters amounted to CNY 56,444,800.51, up from CNY 50,438,435.40, reflecting a growth of 12.4%[38]. Assets and Liabilities - The total assets of the company as of the end of Q3 2022 were ¥2,627,942,203.54, marking a 4.40% increase from the end of the previous year[10]. - The equity attributable to shareholders at the end of Q3 2022 was ¥2,402,308,098.35, which is a 3.59% increase compared to the previous year[10]. - The company's total liabilities increased to CNY 225,634,105.19 from CNY 191,671,437.90, representing a growth of 17.7%[35]. - The total equity attributable to shareholders reached CNY 2,402,308,098.35, compared to CNY 2,319,012,978.77, indicating an increase of 3.6%[37]. Cash Flow - The net cash flow from operating activities for the year-to-date was ¥19,173,291.24, showing a decrease of 26.17% compared to the previous year[10]. - The total cash inflow from operating activities for the first three quarters of 2022 was RMB 441,591,728.88, an increase of 39% compared to RMB 317,481,848.34 in the same period of 2021[46]. - The cash inflow from investment activities totaled RMB 969,045,940.41, significantly up from RMB 251,901,670.18 in the prior year, marking an increase of 284%[47]. - The net cash flow from investment activities was -RMB 839,296,625.28, worsening from -RMB 11,735,941.84 in the same period last year[47]. - The cash inflow from financing activities was RMB 55,643,500.91, compared to RMB 28,749,312.00 in the previous year, reflecting an increase of 94%[47]. - The total cash and cash equivalents at the end of the period amounted to RMB 932,056,988.64, up from RMB 71,018,069.95 at the end of the previous year[47]. Inventory and Receivables - The company's inventory as of September 30, 2022, is ¥235,510,004.96, an increase from ¥157,830,380.08 at the end of 2021[32]. - The company's accounts receivable as of September 30, 2022, amount to ¥136,638,324.98, up from ¥120,125,920.58 at the end of 2021[32]. Business Outlook - The company reported a significant decline in revenue from its automotive business due to delays in the adoption of laser radar technology and changes in client order schedules[26]. - The company has completed the construction of production lines for a key project with Company B, but there are risks regarding the execution of the project on schedule, which may impact future revenues[26]. - The company is optimistic about the future of the laser radar industry and is actively expanding its global customer base for emerging automotive optoelectronic applications[26]. - The company has ongoing projects in automotive midstream modules and upstream components, indicating a focus on market expansion[26].

Financial Performance - The company reported a total revenue of 500 million CNY for the first half of 2022, representing a year-on-year increase of 20%[2] - The company reported a revenue of RMB 100 million for the first half of 2022, representing a year-on-year increase of 20%[19] - The company reported a significant increase in revenue, achieving a total of 1.5 billion in the first half of 2022, representing a year-over-year growth of 25%[28] - The company achieved operating revenue of CNY 263,649,097.40 in the first half of the year, representing a 21.13% increase compared to the same period last year[38] - The company achieved a revenue of 263.65 million RMB in the first half of 2022, reflecting a significant growth compared to the previous year[146] - The company's main revenue for semiconductor laser components and materials in the first half reached 100.16 million yuan, a year-on-year increase of 19.73%[174] - Revenue from laser optical components for "photon control" was 119.85 million yuan, up 19.25% year-on-year, with the fastest growth in light field homogenizers for photolithography applications, increasing by 88.64%[174] - The automotive application revenue was 17.28 million yuan, a decrease of 16.53% year-on-year, primarily due to supply chain impacts from a well-known overseas lidar customer[175] - The revenue from the semiconductor process application reached 39.82 million yuan, a significant increase of 59.83% year-on-year, driven by strong demand in the photolithography market[178] - The medical health application revenue was 54.48 million yuan, reflecting a growth of 28.33% year-on-year, with upstream component revenue increasing by 24.27%[179] User Growth - User data indicates an increase in active users by 15%, reaching a total of 1.2 million users by the end of June 2022[2] - The number of active users reached 1 million, showing a growth of 15% compared to the previous period[19] - User data indicates a growing customer base, with a 30% increase in active users compared to the previous year, reaching 2 million active users[28] Revenue Forecast - The company expects a revenue growth forecast of 25% for the second half of 2022, driven by new product launches and market expansion strategies[2] - The company expects a revenue growth of 25% for the second half of 2022, driven by new product launches and market expansion strategies[19] - The company has provided a positive outlook for the second half of 2022, projecting a revenue growth of 20% to 25% based on current market trends and demand[28] Research and Development - Investment in R&D increased by 30% compared to the previous year, focusing on new technologies in optical components[2] - The R&D investment in new technologies increased by 30% year-on-year, focusing on high-power semiconductor laser devices[19] - The company is investing in R&D, allocating 15% of its revenue towards developing new technologies and improving existing product lines[28] - Research and development expenses accounted for 12.84% of operating revenue, a decrease of 3.35 percentage points compared to the same period last year[35] - The company reported a total R&D investment of approximately ¥33.84 million, a decrease of 3.95% compared to the previous year, with R&D expenses accounting for 12.84% of operating revenue[131] - The R&D personnel count increased to 173, representing 21.98% of the total workforce, compared to 154 and 23.05% in the same period last year[141] - The company has filed for 33 new invention patents and obtained 8 during the reporting period, bringing the total to 725 applications and 236 granted patents[129] - The company has developed nine core technologies, including advanced bonding and thermal management techniques, achieving international leadership in several areas[123] Market Expansion - The company plans to expand its market presence in Southeast Asia, targeting a 10% market share by the end of 2023[2] - The company plans to expand its market presence in Europe and North America, targeting a 10% market share by the end of 2023[19] - The company is focusing on expanding its business in the photon industry, particularly in automotive applications, semiconductor processes, and healthcare[45] - The company is actively expanding into the midstream photon application modules and systems, focusing on automotive, semiconductor processing, and healthcare applications[104] - The company is exploring strategic partnerships for market expansion, particularly in the semiconductor and automotive industries, to leverage synergies and enhance competitive advantage[74] Product Development - The company has launched two new products in Q2 2022, contributing to 15% of total sales in the first half of the year[2] - New product development includes advancements in laser technology, with a focus on enhancing the performance of laser welding and laser annealing systems[25] - The introduction of a new laser diode product line is expected to contribute an additional RMB 50 million in revenue by Q4 2022[19] - The introduction of a new UV-L product line is expected to capture a larger share of the display manufacturing market, particularly in OLED technology[25] - The company is actively developing new products and solutions in the photon application sector to enhance its market position[45] - The company is focused on improving system reliability and manufacturability through the development of solid-state LiDAR technologies[81] Profitability - Net profit attributable to shareholders reached CNY 69,157,735.02, a significant increase of 107.53% year-on-year, driven by revenue growth and improved operational efficiency[38] - The net profit after deducting non-recurring gains and losses was CNY 46,046,315.54, also up by 107.61% compared to the previous year[38] - Basic and diluted earnings per share were both CNY 0.77, reflecting a 57.14% increase year-on-year[39] - The comprehensive gross profit margin for the reporting period was 55.38%, indicating improved profitability[38] - Operating profit reached RMB 76.24 million, up 112.18% compared to the same period last year[172] - The company achieved a net profit attributable to shareholders of 69.16 million yuan, representing a year-on-year increase of 107.53%[148] Supply Chain and Risks - The company has identified potential risks related to supply chain disruptions and is implementing measures to mitigate these risks[2] - The company is facing risks related to the execution of framework agreements, which could adversely affect future revenue and profitability[161] - The company is exposed to foreign exchange risks due to a high proportion of overseas revenue, primarily in euros and US dollars[164] - The company is at risk of asset impairment if future sales of laser stripping optical systems do not meet projected data[163] Strategic Acquisitions - A strategic acquisition of a local competitor is in progress, expected to enhance the company's product offerings and market reach[2] - A strategic acquisition of a competitor is anticipated to enhance the company's product portfolio and increase market competitiveness[19] - A strategic acquisition was completed, enhancing the company's capabilities in optical systems, which is anticipated to drive innovation and market competitiveness[25] - The company signed a strategic supplier contract with Continental Group worth approximately RMB 400 million, with RMB 64.71 million executed as of the reporting period[158] - The framework agreement with Cyden for home medical health application modules is valued at approximately RMB 800 million, with RMB 1.78 million in revenue generated so far[161] Quality Management - Quality management certifications such as ISO9001 and IATF16949 have been maintained, ensuring high standards in production and service delivery[25] - The company established a quality management system that meets ISO9001:2015/IATF16949:2016 standards, emphasizing customer-centric quality improvement[145] Cash Flow and Financial Position - The company's cash flow from operating activities was CNY 6,137,383.39, a decrease of 79.28% from the same period last year[38] - Cash and cash equivalents at the end of the period were 968.55 million yuan, representing 37.13% of total assets, a decrease of 44.53% compared to the previous year[188] - The company's derivative financial assets amounted to 331,547.78, a significant increase of 364.52% compared to the previous year[190] - The company's construction in progress rose by 194.04% to 78,405,220.95, primarily due to investments in the Juguang Technology Dongguan Micro-Optics Project[190] - The company’s undistributed profits reached 61,039,651.79, reflecting continuous profitability during the reporting period[190]

Financial Performance - The company reported a cumulative undistributed profit of negative value as of December 31, 2021, and will not proceed with profit distribution [5]. - The company has not achieved profitability since its listing, indicating ongoing financial challenges [4]. - The company reported a total revenue of RMB 1.5 billion for the fiscal year 2021, representing a year-over-year growth of 25% [16]. - The company reported a significant increase in revenue, achieving a total of $150 million for the fiscal year, representing a 25% year-over-year growth [22]. - The company achieved operating revenue of RMB 475,804,602.28 in 2021, representing a year-on-year increase of 32.21% [31]. - The net profit attributable to shareholders was RMB 67,761,555.25, a significant increase of 94.33% compared to the previous year [35]. - The net profit after deducting non-recurring gains and losses reached RMB 48,520,651.94, marking a 148.35% increase year-on-year [31]. - The company reported quarterly revenues of RMB 132,910,153.07 in Q4 2021, with a net profit of RMB 10,865,747.37 for the same period [38]. - The company achieved a total revenue of 475.80 million RMB, representing a year-on-year growth of 32.21% compared to 2020 [52]. - The total profit reached 76.67 million RMB, with a year-on-year increase of 102.62% [52]. - The company’s cash flow from operating activities was RMB 41,761,491.39, up 12.89% from the previous year [31]. - The net cash flow from financing activities surged by 886.96% to ¥1,630,695,983.98 from ¥165,224,749.02, primarily due to the completion of the initial public offering [174]. Research and Development - The company has invested RMB 200 million in R&D for new semiconductor laser technologies, aiming to enhance product efficiency and performance [16]. - Research and development expenses increased by 10%, totaling $20 million, focusing on advanced laser technologies [22]. - Research and development expenses accounted for 14.25% of operating revenue, a decrease of 5.17 percentage points from the previous year [34]. - The company achieved a total R&D investment of ¥6,778.64 million in the current year, a decrease of 3.02% compared to the previous year [138]. - R&D investment accounted for 14.25% of total operating revenue, down from 19.42% in the previous year, reflecting a 5.17% decline [138]. - The company holds a total of 1,219 intellectual property rights, with 52 new applications filed during the reporting period [136]. - The company has developed a new automotive laser radar light source with an expected total investment of ¥1,500 million, achieving batch production [141]. - The company has developed a DUV lithography homogenization module, achieving an industry-leading level and filling a domestic gap, with a development cost of 380 million RMB [145]. - The company has developed a home-use laser skin rejuvenation module, currently in the product development stage, with an investment of 360 million RMB, marking a pioneering product in the beauty anti-aging field [145]. Market Expansion and Strategy - The company plans to expand its market presence in Europe and North America, targeting a 15% market share in these regions by 2023 [16]. - The company is exploring potential acquisitions to enhance its product portfolio and market reach, with a budget of RMB 500 million allocated for this purpose [16]. - The company is focusing on expanding its market presence in high-end manufacturing, artificial intelligence, and life sciences through innovative applications of semiconductor laser technology [124]. - The company is actively pursuing market expansion strategies in the field of medical aesthetics, focusing on the development of specialized medical devices and modules [83]. - The company has established strategic partnerships with globally renowned medical device companies, enhancing its market position and customer resource accumulation [121]. - The company has signed a 400 million RMB framework agreement for laser radar transmission modules, indicating significant market potential despite current revenue growth challenges [160]. - The company has a framework cooperation agreement with Cyden for laser medical beauty products valued at approximately RMB 800 million, with delays in clinical trials and certifications expected to push revenue growth to 2023 [164]. Product Development and Innovation - The company has launched a new high-power semiconductor laser product line, which is expected to contribute an additional RMB 300 million in revenue in the next fiscal year [16]. - New product launches included a state-of-the-art laser processing system, expected to enhance production efficiency by 40% [22]. - The company has developed a solid-state laser technology that produces high peak power infrared laser beams, with a detection field of view angle of 120°x20° and operational temperature range from -40°C to +110°C [92]. - The company has achieved breakthroughs in key technologies for the preparation of preform gold-tin films, breaking the long-standing foreign monopoly and now supplying these products to major global fiber laser manufacturers [121]. - The company’s laser technology is applied in various fields, including intelligent driving, machine vision, and security monitoring [92]. - The company has developed a high aspect ratio optical shaping technology, leading to improved efficiency in industrial applications [135]. - The company has established a comprehensive testing and diagnostic model for high-power semiconductor laser devices, enhancing its product performance evaluation capabilities [135]. Risks and Challenges - The company faces risks related to core technology leakage and talent loss, which could adversely affect its competitive edge in the semiconductor laser and optics industry [161]. - The company has a significant gap in product layout compared to international leaders, which may hinder its market expansion and competitiveness in the midstream photon application modules [165]. - The company reported a risk of asset impairment due to potential bad debts from clients, despite currently having a good collection rate [166]. - The company is exposed to foreign exchange risks due to a high proportion of overseas revenue, primarily in euros and US dollars [168]. - The company is actively seeking to mitigate risks from international political and economic changes that could impact its cross-border operations and supply chain [172]. - The company has experienced delays in product development and market entry, with expectations for significant revenue growth starting in 2023 [164]. Operational Efficiency - The company has established an agile manufacturing system to quickly respond to diverse market demands, combining order-based production with sales forecasting [110]. - The company emphasizes automation and information technology in production, leading to continuous improvements in product performance, yield, and reliability [110]. - The company implements a comprehensive quality control process for product storage and shipment, ensuring customer satisfaction through effective after-sales service [109]. - The integration of optical systems with information technology and advanced manufacturing is expected to drive innovation and cross-industry applications [116].

2022 年第一季度报告 单位：元币种：人民币 证券代码：688167 证券简称：炬光科技 西安炬光科技股份有限公司 2022 年第一季度报告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存 在虚假记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务报表 信息的真实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一)主要会计数据和财务指标 本报告期比上年 | --- | --- | --- | |-----------------------------------------------|----------------|-----------------------| | 项目 | 本报告期 | 同期增减变动幅 度 (%) | | 营业收入 | 110,523,014.75 | 20.77 | | 归属于上 ...